Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Alto Neuroscience, Inc. ( (ANRO) ) just unveiled an announcement.
On October 19, 2025, Alto Neuroscience, Inc. announced a private placement agreement with institutional investors to raise approximately $50 million. The proceeds will be used to accelerate the development of ALTO-207, a treatment for treatment-resistant depression, following a successful FDA meeting. This financing, led by Perceptive Advisors, positions Alto to advance its clinical trials, with plans to initiate a Phase 2b study by mid-2026 and a Phase 3 study by early 2027. Additionally, Alto terminated a previous sales agreement with Leerink Partners LLC, having not sold any shares under that agreement.
The most recent analyst rating on (ANRO) stock is a Buy with a $16.00 price target. To see the full list of analyst forecasts on Alto Neuroscience, Inc. stock, see the ANRO Stock Forecast page.
Spark’s Take on ANRO Stock
According to Spark, TipRanks’ AI Analyst, ANRO is a Neutral.
Alto Neuroscience, Inc. faces significant financial challenges with zero revenue, increasing losses, and negative cash flows, reflecting in a low financial performance score. Despite some technical indicators suggesting short-term upward momentum, the stock’s valuation remains risky due to a negative P/E ratio and lack of dividends, resulting in an overall low stock score.
To see Spark’s full report on ANRO stock, click here.
More about Alto Neuroscience, Inc.
Alto Neuroscience, Inc. is a clinical-stage biopharmaceutical company focused on developing novel precision medicines for neuropsychiatric disorders. The company leverages its Precision Psychiatry Platform to develop personalized treatment options, with a clinical-stage pipeline that includes drug candidates for conditions such as bipolar depression, major depressive disorder, treatment-resistant depression, and schizophrenia.
Average Trading Volume: 1,131,301
Technical Sentiment Signal: Buy
Current Market Cap: $164.6M
For a thorough assessment of ANRO stock, go to TipRanks’ Stock Analysis page.